secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2022-04-08T23:59:59+00:00
Accession:  0001628280-22-008833
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex board member Jeffery Baxter resigns effective April 4, 2022
---------------------------------------------------------------------

- Jeffery Baxter resigned from the board and its Audit and Nominating/Governance committees on April 4, 2022.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Company has not announced a replacement at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022008833/0001628280-22-008833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022008833/cdxc-20220404.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-008833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer